Tykerb and Clozaril among formal Japanese approvals
This article was originally published in Scrip
Executive Summary
Japan's ministry of health, labour and welfare has formally approved a number of products given positive recommendations by an advisory committee last month, including GlaxoSmithKline's Tykerb and Novartis's Clozaril.